Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02500199 |
| Title | Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Hengrui Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, Irvine School of Medicine | Orange | California | 92868 | United States | Details | |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Henry Ford Health System | Detroit | Michigan | 48202 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
| South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | United States | Details |